GlassScriptPhysician profile
David L Benson
NPI 1417367103
$8,729.96
in general payments reported to CMS, 2019-2025
18 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,999 · 2020: $257 · 2021: $1,318 · 2022: $542 · 2023: $2,729 · 2024: $412 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,026 · Food and Beverage: $1,588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,025.97 |
| Food and Beverage | $1,588.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,858.04 | 2019 | |
| Boston Scientific Corporation | $2,774.54 | 2020-2025 | Intracept, Watchman Flx |
| Pacira Pharmaceuticals Incorporated | $1,053.94 | 2021-2022 | |
| Abbott Laboratories | $688.17 | 2019-2025 | Proclaim, Eterna |
| Spr Therapeutics, INC | $589.41 | 2022-2025 | Sprint Pns System |
| Averitas Pharma INC. | $373.32 | 2023-2025 | Qutenza |
| Grt US Holding, INC. | $84.83 | 2021-2022 | |
| Medtronic, INC. | $68.03 | 2024-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Abbvie INC. | $36.44 | 2024 | |
| Si-Bone, INC. | $31.40 | 2021-2024 | |
| Bioventus LLC | $28.73 | 2024-2025 | Durolane |
| Nevro Corp. | $28.32 | 2019 | |
| Pfizer INC. | $27.88 | 2019-2020 | |
| Saluda Medical Americas, INC. | $25.39 | 2025 | Evoke |
| Vertiflex, INC. | $20.40 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $15.22 | 2024 | Painteq |
| Pharmacosmos Therapeutics INC. | $15.14 | 2023 | Monoferric |
| Vertos Medical, INC. | $10.76 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.